Rezultati - Isabel Smith Zubiaga
- Showing 1 - 2 results of 2
-
1
Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer od Helmout Modjtahedi, Tamas Hickish, Margery Nicolson, J. Moore, JM Styles, S. A. Eccles, Elise Jackson, Janine Salter, John Sloane, M. Loreto Spencer, K. Priest, Isabel Smith Zubiaga, Christopher Dean, M. Gore
Izdano 1996Artigo -
2
Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics od Michael J. Ellis, Yu Tao, Jingqin Luo, Roger A’Hern, Dean B. Evans, A.S. Bhatnagar, Hilary A. Chaudri Ross, Alexander von Kameke, William R. Miller, Isabel Smith Zubiaga, W. Eiermann, Mitch Dowsett
Izdano 2008Artigo
Iskalna orodja:
Sorodne teme
Cancer
Internal medicine
Medicine
Anastrozole
Antibody
Biochemistry
Biology
Biomarker
Breast cancer
Carcinoma
Chemistry
Epidermal growth factor receptor
Epidermoid carcinoma
Estrogen receptor
Gynecology
Immunology
Letrozole
Lung cancer
Monoclonal
Monoclonal antibody
Neoadjuvant therapy
Oncology
Paleontology
Pathology
Proportional hazards model
Squamous-cell carcinoma of the lung
Stage (stratigraphy)
Tamoxifen
Toxicity